Advertisements



Jazz settled patent dispute with Amneal Pharmaceuticals

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 11th, 2018

Amneal wins patent challenge against Jazz Pharmaceuticals" Xyrem, Bloomberg says

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 13th, 2018

U.S. top court rejects Amgen over cholesterol medication patent fight

The U.S. Supreme Court on Monday declined to take up Amgen Inc's bid to reinstate a jury verdict it won against rivals Regeneron Pharmaceuticals Incand Sanofi SAin a patent dispute over cholesterol medication......»»

Category: topSource: reutersJan 7th, 2019

Teva shares surge 5% on news of patent settlement with Neos over ADHD drug

Shares of generic drug maker Teva Pharmaceuticals Industries Ltd. rose about 5% Wednesday on news of a settlement and licensing agreement with Neos Therapeutics Inc. to resolve a patent dispute about a treatment for attention deficit disorders, or ADHD......»»

Category: topSource: marketwatchDec 26th, 2018

Amneal Pharmaceuticals issued new patent for investigational Parkinson"s formula

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 24th, 2018

Jazz Pharmaceuticals patent ruling a "non-issue, says Evercore ISI

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 13th, 2018

Jazz Sells Pain Drug Prialt"s Rights to TerSera Therapeutics

Jazz Pharmaceuticals (JAZZ) signs a definitive contract to sell its Prialt rights to TerSera Therapeutics for a settled amount of $80 million in cash upon its closure. .....»»

Category: worldSource: nytJul 2nd, 2018

The Apple-Samsung "thermonuclear war" over Android is over, but at least we got these iPhone prototype photos out of the battle (AAPL)

Court filing Apple and Samsung settled a seven-year patent dispute earlier this week. The terms of the settlement aren't known.   For most people and Apple fans, there are no easy takeaways from the end of the case.&nbs.....»»

Category: topSource: businessinsiderJun 30th, 2018

Amneal Pharmaceuticals announces favorable ruling on patent validity for Zomig

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 29th, 2018

Apple Inc. (NASDAQ:AAPL) Samsung settle U.S. patent dispute

Apple Inc. (NASDAQ:AAPL) Samsung settle U.S. patent dispute pple Inc and Samsung Electronics Co Ltd on Wednesday settled a seven-year patent dispute over Apple’s allegations that Samsung violated its patents by “slavishly” copying the .....»»

Category: topSource: livetradingnewsJun 28th, 2018

Apple and Samsung Settle Seven-Year-Old iPhone Patent Dispute

Apple and Samsung Electronics have settled a yearslong dispute focused on whether Samsung’s phone designs violated Apple’s patents......»»

Category: smallbizSource: wsjJun 27th, 2018

Finally over: Samsung and Apple settle longstanding patent dispute

Seven years after it began, Samsung and Apple settled a patent dispute that at one point went to the Supreme Court. Term.....»»

Category: topSource: usatodayJun 27th, 2018

The Wall Street Journal: Apple and Samsung reach settlement to end 7-year patent dispute

Apple Inc. and Samsung Electronics Co. have settled a yearslong dispute focused on whether Samsung’s phone designs violated Apple’s patents......»»

Category: topSource: marketwatchJun 27th, 2018

Apple and Samsung just settled their 7-year dispute over alleged patent violations

Richard Drew/AP Apple and Samsung have settled their seven-year dispute over alleged patent violations. The dispute began when Apple alleged that Samsung .....»»

Category: topSource: businessinsiderJun 27th, 2018

Apple, Samsung settle U.S. patent dispute

Apple Inc and Samsung Electronics Co Ltd on Wednesday settled a years’ long patent dispute, according to a filing the U.S. District Court for the Northern District of California. The terms of the settlement were not disclosed in the court filing......»»

Category: topSource: moneycentralJun 27th, 2018

Jazz Pharmaceuticals" Sunosi for excessive daytime sleepiness approved by FDA

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 20th, 2019

Jazz Pharmaceuticals" Sleep Drug NDA Awaits FDA Decision

The FDA will provide its decision on Jazz's (JAZZ) candidate, solriamfetol, for excessive daytime sleepiness with narcolepsy on Wedne.....»»

Category: worldSource: nytMar 20th, 2019

FDA PDUFA Date for Jazz Pharmaceuticals Solriamfetol is March 20, 2019

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 20th, 2019

Jazz Pharmaceuticals initiated with a Buy at SunTrust

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 19th, 2019

Amneal Pharmaceuticals initiated with a Buy at SunTrust

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 19th, 2019

FDA decision on Jazz Pharmaceuticals narcolepsy drug expected Wednesday

The Food and Drug Administration is expected to make a decision by Wednesday on a new drug application filed by Jazz Pharmaceuticals for its experimental narcolepsy drug solriamfetol. The FDA was originally set to make a ruling on the application i.....»»

Category: topSource: bizjournalsMar 19th, 2019